In addition to their actions on reproductive function, estrogens have important effects on endothelial cells. The present study was designed to evaluate the mechanism(s) by which 17β-estradiol (E2) promotes endothelial cell proliferation. The potential involvement of vascular endothelial growth factor (VEGF) was investigated by the coadministration of polyclonal anti-VEGF antibody. First, the effect of E2 on the proliferation of cultured foetal bovine aortic endothelial cells (FBAEC) was studied. E2 stimulated this proliferation with an EC50 between 10–11 and 10–10 M and this effect was inhibited by the anti-VEGF antibody. The effect of a physiological dose of E2 was then studied in the rat model of carotid injury. After deendothelializing balloon injury, reendothelialization of the denuded surface may influence the growth of the underlying smooth muscle cells. Male Sprague-Dawley rats were castrated and then received E2 from subcutaneously implanted pellets that released 3.2 μg/kg/day. Endothelial regrowth (Evans blue staining) and neointimal thickening were evaluated 2 weeks after the carotid injury. In comparison to the placebo group, E2 increased the extent of reendothelialization (p = 0.0002) and reduced neointimal thickening (p = 0.0007). Anti-VEGF antibody abolished the effect of E2 on reendothelialization as well as on neointimal thickening. Thoracic aorta VEGF content was increased in E2-treated rats compared to control rats. In conclusion, the present study demonstrates that E2 increases endothelial cell proliferation in vitro and reendothelialization in vivo by means of a mechanism dependent on endogenous VEGF. This effect could contribute to the antiatherogenic effect of a physiological dose of E2.

Keywords:
Endothelial cell, 17β-Estradiol, Carotid artery, rat, Vascular endothelial growth factor
1.
Hough IL, Zilversmit DB: Effect of 17β-estradiol on aortic cholesterol content and metabolism in cholesterol-fed rabbits. Arteriosclerosis 1986;6:57–63.
2.
Adams MR, Kaplan JR, Manuck SB, Koritnik DR, Parks JS, Wolfe MS, Clarkson TB: Inhibition of coronary artery atherosclerosis by 17β-estradiol in ovariectomized monkeys. Lack of an effect of added progesterone. Arteriosclerosis 1990;10:1051–1057.
3.
Gilligan DM, Quyyumi AA, Cannon RO, Johnson GB, Schenke WH: Effects of physiological levels of estrogen on coronary vasomotor function in postmenopausal women. Circulation 1994;89:2545–2551.
4.
Bayard F, Clamens S, Delsol G, Blaes N, Maret A, Faye J-C: Oestrogen synthesis, oestrogen metabolism and functional oestrogen receptors in bovine aortic endothelial cells. Ciba Found Symp 1995;191:122–138.
5.
Gisclard V, Miller VM, Vanhoutte P: Effect of 17β-estradiol on endothelium-dependent responses in the rabbit. J Pharmacol Exp Ther 1988;244:19–22.
6.
Hayashi T, Fukuto JM, Ignarro LJ, Chaudhuri G: Basal release of nitric oxide from aortic rings is greater in female rabbits than in male rabbits: Implications for atherosclerosis. Proc Natl Acad Sci USA 1992;89:11259–11263.
7.
Arnal JF, Clamens S, Pechet C, Nègre-Salvayre A, Allera C, Girolami JP, Salvayre R, Bayard F: Ethinylestradiol does not enhance the expression of nitric oxide synthase in bovine aortic endothelial cells but increases the release of bioactive nitric oxide by inhibiting superoxide anion production. Proc Natl Acad Sci USA 1996;93:4108–4113.
8.
Alvarez RJ, Sanford J, Moldovan N, Wilhide C, Milliken E, Hoang A, Hruban R, Silverman H, Dang C, Goldschmidt-Clermont P: 17β-Estradiol inhibits apoptosis of endothelial cells. Biochem Biophys Res Commun 1997;237:372–381.
9.
Spyridopoulos I, Sullivan A, Kearney M, Isner J, Losordo D: Estrogen-receptor-mediated inhibition of human endothelial cell apoptosis. Circulation 1997;95:1505–1514.
10.
Morales D, McGowan K, Grant D, Maheshwari S, Bhartiya D, Cid M, Kleinman H, Schnaper H: Estrogen promotes angiogenic activity in human umbilical vein endothelial cells in vitro and in a murine model. Circulation 1995;91:755–763.
11.
Krasinski K, Spyridopoulos I, Asahara T, van der Zee R, Isner JM, Losordo DW: Estradiol accelerates functional endothelial recovery after arterial injury. Circulation 1997;95:1768–1772.
12.
Clowes AW, Collazzo RE, Karnovsky MJ: A morphologic and permeability study of luminal smooth muscle cells after arterial injury in the rat. Lab Invest 1978;39:141–150.
13.
Reidy MA, Clowes AW, Schwartz SM: Endothelial regeneration. V. Inhibition of endothelial regrowth in arteries of rat and rabbit. Lab Invest 1983;49:569–575.
14.
Furchgott RF, Vanhoutte PM: Endothelium-derived relaxing and contracting factors. FASEB J 1989;3:2007–2018.
15.
Asahara T, Bauters C, Pastore BS, Kearney M, Rossow S, Bunting S, Ferrara N, Symes JF, Isner JM: Local delivery of vascular endothelial growth factor accelerates reendothelialization and attenuates intimal hyperplasia in balloon-injured rat carotid artery. Circulation 1995;91:2793–2801.
16.
Jonca F, Ortéga N, Gleizes P, Bertrand N, Plouët J: Cell release of bioactive fibroblast growth factor 2 by exon 6-encoded sequence of vascular endothelial growth factor. J Biol Chem 1997;272:24203–24209.
17.
Plouët J, Moukadiri H: Specific binding of vasculotropin to bovine brain capillary endothelial cells. Biochimie 1990;72:51–55.
18.
Simorre-Pinatel V, Guerrin M, Chollet P, Penary M, Clamens S, Malecaze F, Plouet J: Vasculotropin-VEGF stimulates retinal capillary endothelial cells through an autocrine pathway. Invest Ophthalmol Vis Sci 1994;35:3393–3400.
19.
Berard M, Sordello S, Ortega N, Carrier JL, Peyri N, Wassef M, Bertrand N, Enjolras O, Drouet L, Plouet J: Vascular endothelial growth factor confers a growth advantage in vitro and in vivo to stromal cells cultured from neonatal hemangiomas. Am J Pathol 1997;150:1315–1326.
20.
Lindner V, Kim SK, Karas RH, Kuiper GGJM, Gustafsson JA, Mendelsohn ME: Increased expression of estrogen receptor-beta mRNA in male blood vessels after vascular injury. Circ Res 1998;83:224–229.
21.
Wade GN, Heller H: Tamoxifen mimics the effect of estradiol on food intake, body weight, and body composition in rats. Am J Physiol 1993;264:R1219–R1223.
22.
Nègre-Salvayre A, Pieraggi MT, Mabile L, Salvayre R: Protective effect of 17b-estradiol against the cytotoxicity of minimally oxidized LDL to cultured bovine aortic endothelial cells. Atherosclerosis 1993;99:207–217.
23.
Rifici VA, Khachadurian AK: The inhibition of low-density lipoprotein oxidation by 17-b estradiol. Metabolism 1992;41:1110–1114.
24.
Foegh ML, Asotra S, Howell MH, Ramwell PW: Estradiol inhibition of arterial neointimal hyperplasia after balloon injury. J Vasc Surg 1994;19:722–726.
25.
Sullivan TR, Karas RH, Aronovitz M, Faller GT, Ziar JP, Smith JJ, Odonnell TF, Mendelsohn ME: Estrogen inhibits the response-to-injury in a mouse carotid artery model. J Clin Invest 1995;96:2482–2488.
26.
Elhage R, Arnal JF, Pierragi M-T, Duverger N, Fiévet C, Faye JC, Bayard F: Estradiol-17β prevents fatty streak formation in apolipoprotein E-deficient mice. Arterioscler Thromb Vasc Biol 1997;17:2679–2684.
27.
Barbacanne MA, Rami J, Michel JB, Philippe M, Souchard JP, Besombes JP, Bayard F, Arnal JF: Estradiol decreases endothelium-derived superoxide anion in rat aorta. Effect on NO bioactivity and peroxynitrite production. Cardiovasc Res 1999;41:672–681.
28.
Vargas R, Wroblewska B, Rego A, Hatch J, Ramwell PW: Estradiol inhibits smooth muscle cell proliferation of pig coronary artery. Br J Pharmacol 1993;109:612–617.
29.
Keaney JF, Shwaery GT, Xu AM, Nicolosi RJ, Loscalzo J, Foxall TL, Vita JA: 17β-Estradiol preserved endothelial vasodilator function and limits low-density lipoprotein oxidation in hypercholesterolemic swine. Circulation 1994;89:2251–2259.
30.
Garg UC, Hassid A: Nitric oxide-generating vasodilators and 8-bromo-cyclic quanosine monophosphate inhibit mitogenesis and proliferation of cultured rat vascular smooth muscle cells. J Clin Invest 1989;83:1774–1777.
31.
Weiner CP, Lizasoain I, Baylis SA, Knowles RG, Charles IG, Moncada S: Induction of calcium-dependent nitric oxide synthases by sex hormones. Proc Natl Acad Sci USA 1994;91:5212–5216.
32.
Couffinhal T, Kearney M, Witzenbichler B, Chen D, Murohara T, Losordo D, Symes J, Isner J: Vascular endothelial growth factor/vascular permeability factor (VEGF/VPF) in normal and atherosclerotic human arteries. Am J Pathol 1997;150:1673–1685.
33.
Asahara T, Murohara T, Sullivan A, Silver M, van der Zee R, Li T, Witzenbichler B, Schatteman G, Isner J: Isolation of putative progenitor endothelial cells for angiogenesis. Science 1997;275:964–967.
34.
Ziche M, Morbidelli L, Choudhuri R, Zhang HT, Donnini S, Granger HJ, Bicknell R: Nitric oxide synthase lies downstream from vascular endothelial growth factor-induced but not basic fibroblast growth factor-induced angiogenesis. J Clin Invest 1997;99:2625–2634.
35.
Chang E, Harley CB: Telomere length and replicative aging in human vascular tissues. Proc Natl Acad Sci USA 1995;92:11190–11194.
© 2000 S. Karger AG, Basel
2000
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.